FDA Approves PrecisionOS Invision as a VR Preoperative Assessment and Planning Tool
PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to begin marketing PrecisionOS Invision™ a patient-specific planning tool using Virtual Reality (VR). The patented software, to be available in early 2022, lets surgeons use an Oculus Quest 2 device to do preoperative planning and preoperative assessment.
Invision is a next generation patient-specific planning tool. Currently surgeons view a simulated 3D image of the patient on a computer screen through virtual surgical planning and then carry that mental model to the operating room. Invision software automatically converts the patient’s computed tomography (CT) scan from any PACS system into a 3D reconstruction within seconds. Surgeons can then use the Oculus Quest 2 to view, manipulate and isolate relevant anatomical areas prior to performing the actual surgical procedure.